PACTR201905507865682招募中2 期
Effect of niacin on hyperphosphatemia in chronic kidney disease (stages 3-5) patients. A randomized double blind placebo controlled trial.
Edema Oritseweyinmi Great0 个研究点目标入组 120 人开始时间: 2019年4月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Inclusion Criteria
- •CKD stages 3-5 patients who are aged 18 years -80 years.
- •Capable of giving informed consent
- •Serum phosphate levels 5-7 mg/dl
- •Unchanged treatment protocol (calcium carbonate and vitamin D) during last 2 weeks.
排除标准
- •Unwillingness to participate in the study.
- •Known liver disease,
- •Active peptic ulcer disease
- •Necessity of changing treatment protocol because of safety criteria (such as severe hyperphosphatemia or two consecutive serum phosphorus levels > 7 mg/dl)
- •Age greater than 80 years
研究者
相似试验
进行中（未招募）
不适用
Efficacy of niacin on phosphatic metabolism in patients with renal insufficiencyEUCTR2005-002221-31-DEClinic for Nephrology30
Unknown
4 期
The Efficacy of Niacin on Hyperphosphatemia in Patients Undergoing HaemodialysisHyperphosphatemiaNCT03163576Assiut University150
已完成
不适用
The effects of nicotinic acid on hyperphosphatemia in dialysis patients of valiasr-Arak centerHyperphosphatemia.disorder of phosphorus metabolismIRCT138812153492N1Depuity of education & research of Arak university of Medical science30
尚未招募
3 期
The effect of niacin on sodium, phosphorus, parathyroid hormone (PTH) and vitamin D levelsIRCT20190702044076N2Shahre-kord University of Medical Sciences60
已完成
1 期
The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis PatientsHyperphosphatemiaNCT00316472Washington University School of Medicine40